Chronic hepatitis B update showing current antiviral therapy, HBsAg loss as the functional cure endpoint, and investigational finite therapy.
Blog

Chronic Hepatitis B in 2026: EASL 2025, Functional Cure, and What Still Belongs in Practice

A physician-facing update on chronic hepatitis B after the 2025 EASL guideline: functional cure goals, current nucleos(t)ide analog strategy, investigational RNA-directed therapies, and clinic workflow.